Can change in gut microbiota composition be used as a surrogate marker of treatment efficacy of ketogenic diet in patients with drug-resistant epilepsy?

Thambi, Magith; Nathan, Janak; Radhakrishnan, Kurupath

Thambi, Magith; Nathan, Janak; Radhakrishnan, Kurupath.

Affiliation

Thambi M; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
Nathan J; Sanjeev Clinic, Mahim, Mumbai, Maharashtra 400016, India.
Radhakrishnan K; Department of Neurosciences, Avitis Institute of Medical Sciences, Palakkad, Kerala 678508, India. Electronic address: drradhakrishnan.k@avitishospital.com.

Epilepsy Behav ; 113: 107444, 2020 12.

Article in En | MEDLINE | ID: mdl-33091747

Subject(s)

Diet, Ketogenic; Epilepsy; Gastrointestinal Microbiome; Pharmaceutical Preparations; Biomarkers; Epilepsy/drug therapy; Humans; Treatment Outcome

Key words

Drug-resistant epilepsy; Epilepsy; Gut microbiota; Ketogenic diet; Microbiome; Surrogate marker

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmaceutical Preparations / Epilepsy / Diet, Ketogenic / Gastrointestinal Microbiome Type of study: Clinical_trials / Observational_studies Limits: Humans Language: En Journal: Epilepsy Behav Journal subject: CIENCIAS DO COMPORTAMENTO / NEUROLOGIA Year: 2020 Document type: Article Affiliation country: India Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google